Crossmark Global Holdings’s Halozyme HALO Stock Holding History

Crossmark Global Holdings’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Buy	3,438 +151	+5%	+$10.3K	﹤0.01%	1112
2026 Q1	$212K	Sell	3,287 -66	-2%	-$4.65K	﹤0.01%	1178
2025 Q4	$226K	Buy	+3,353	New	+$226K	﹤0.01%	1145
2023 Q1	–	Sell	-18,928	Closed	-$1.08M	–	1303
2022 Q4	$1.08M	Sell	18,928 -4,194	-18%	-$215K	0.03%	548
2022 Q3	$914K	Sell	23,122 -654	-3%	-$28.9K	0.03%	569
2022 Q2	$1.05M	Sell	23,776 -2,750	-10%	-$119K	0.03%	553
2022 Q1	$1.06M	Buy	26,526 +4,450	+20%	+$159K	0.02%	599
2021 Q4	$888K	Buy	22,076 +1,760	+9%	+$65.7K	0.02%	666
2021 Q3	$826K	Buy	20,316 +46	+0.2%	+$1.92K	0.02%	675
2021 Q2	$920K	Sell	20,270 -30	-0.1%	-$1.33K	0.02%	644
2021 Q1	$846K	Buy	20,300 +330	+2%	+$15.1K	0.02%	653
2020 Q4	$853K	Buy	+19,970	New	+$718K	0.02%	614

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Crossmark Global Holdings's HALO Position: Q2 2026 in Review

Crossmark Global Holdings increased its Halozyme (HALO) stake by 4.6% in Q2 2026, buying an estimated $10.3K and bringing the position to 3,438 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Crossmark Global Holdings first reported a position in HALO in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.08M in Q4 2022. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Crossmark Global Holdings held 3,438 shares of Halozyme worth $269K as of Q2 2026.
Crossmark Global Holdings bought 151 Halozyme shares in Q2 2026, an estimated $10.3K.
Halozyme made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1112 holding.
Crossmark Global Holdings first reported a position in Halozyme in Q4 2020 and has held it in 12 quarters since.
Crossmark Global Holdings's Halozyme position peaked at $1.08M in Q4 2022.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.